Form 10-Q · Quarterly report
Steris 10-Q, filed Nov 5, 2026
- Filed
- CIK
- 0001757898
- Accession no.
- 0001628280-26-070997
Summary
Steris reported higher revenue and operating income for the second quarter and first half of fiscal 2027, and said it agreed to acquire Xodus Medical for about $2.1 billion in cash plus up to $150 million in potential earnout consideration, expected to close by December 31, 2026.
Key points
- Steris revenues rose 8.8% to $1,588.6 million in the second quarter of fiscal 2027 and 8.1% to $3,081.3 million for the first six months.
- Income from operations was $294.3 million in the quarter, compared with $265.8 million a year earlier.
- Steris completed three tuck-in acquisitions in the first six months of fiscal 2027 for total aggregate consideration of about $17.3 million.
- Steris said it expects to close the Xodus Medical acquisition by December 31, 2026, subject to customary closing conditions and regulatory approvals.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Introduction In Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”), we explain the general financial condition and the results of operations for STERIS and its subsidiaries including: •what factors affect our business; •what our earnings and costs were in each period presented; •why those earnings and costs were different from prior periods; •where our earnings came from; •how this affects our overall financial condition; •what our expenditures for capital projects were; …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.